<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="474315" id="root" date="1997-03-28" xml:lang="en">
<title>USA: IVAX to countersue Bergen Brunswig.</title>
<headline>IVAX to countersue Bergen Brunswig.</headline>
<dateline>WASHINGTON 1997-03-28</dateline>
<text>
<p>IVAX Corp said Friday it would file a lawsuit against Bergen Brunswig Corp, which already has sued IVAX, charging it with breach of agreement in connection with the termination of their merger deal.</p>
<p>Bergen Brunswig on March 20 called off a previously announced $1.6 billion merger agreement with IVAX and filed a suit against the Miami holding company of health-care product subsidiaries in U.S. District Court in New York last Friday.  </p>
<p>But in a filing with the Securities and Exchange Commission, IVAX said Friday that it does not believe the Orange, Calif.-based drug wholesaler had a legal right to end their merger pact and &quot;intends to defend the suit vigorously and pursue a counterclaim for breach of agreement&quot; by Bergen Brunswig.</p>
<p>IVAX said Friday that it has a stake of 12,157,432 Class A common shares of Bergen Brunswig, or 24.3 percent of the total.</p>
<p>But in its orginal filing on Bergen Brunswig in November, IVAX reported that its stake consisted of an option from Bergen Brunswig to buy up to 9,953,076 shares and a voting agreement with Bergen Brunswig Chief Executive Officer Robert Martini, who represented that he then owned 2,137,958 shares.</p>
<p>Lisa Riordan, director of investor relations at Bergen Brunswig, said her company was unaware of any stake held by IVAX in Bergen Brunswig besides the option.</p>
<p>&quot;We're not aware of any investment in our company by IVAX,&quot; Riordan said.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
  <code code="I61000">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C12">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
  <code code="C18">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
  <code code="C181">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
  <code code="GCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
  <code code="GCRIM">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-28"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-03-28"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-03-28"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="WASHINGTON"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
